The landscape of infectious disease diagnosis is undergoing a swift transformation, driven by the shift from centralized laboratories to decentralized testing locations. This movement is particularly impactful within the CT/NG testing market, where timely results are critical for patient management and preventing further transmission of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG)....